Patients using therapies that require extended REMS monitoring face challenges beyond just managing their care. They may be overloaded with complicated, clinical information with limited tools to effectively monitor for adverse events. Frequent lab tests can take their toll in both time and money. In addition to the administrative burden, the emotional burden on themselves and their caregivers can be substantial. BrightInsight’s Disease Management Solution can be easily configured to ease the burden of REMS monitoring—bringing much needed peace of mind to patients and helping biopharma companies adhere to their REMS protocols.